Evidence map›Paper›PMID 40000465›Full record

ArticleEuropean journal of ageing2025

The potential of depressive symptoms to identify cognitive impairment in ageing.

Panagiotis Alexopoulos, Christos Bountoulis, Everina Katirtzoglou, Mary H Kosmidis, Kostas Siarkos, Mary Yannakoulia, Efthimios Dardiotis, Maria Skondra, Georgios Hadjigeorgiou, Robert Perneczky and 10 more

Abstract read
In one paragraph

Article in European journal of ageing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Panagiotis AlexopoulosDepartment of Medicine, School of Health Sciences, Mental Health Services, Patras University General Hospital, University of Patras, 26504, Rio, Patras, Greece. panos.alexopoulos@upatras.gr.
Christos BountoulisDepartment of Business Administration, University of Piraeus, Piraeus, Greece.
Everina Katirtzoglou1st Department of Psychiatry, Eginition Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Mary H KosmidisLab of Cognitive Neuroscience, School of Psychology, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Kostas Siarkos1st Department of Psychiatry, Eginition Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Mary YannakouliaDepartment of Nutrition and Dietetics, Harokopio University, Athens, Greece.
Efthimios DardiotisDepartment of Neurology, Larissa University General Hospital, School of Medicine, University of Thessaly, Larissa, Greece.
Maria SkondraDepartment of Medicine, School of Health Sciences, Mental Health Services, Patras University General Hospital, University of Patras, 26504, Rio, Patras, Greece.
Georgios HadjigeorgiouDepartment of Neurology, Larissa University General Hospital, School of Medicine, University of Thessaly, Larissa, Greece.
Robert PerneczkyDivision of Mental Health in Older Adults and Alzheimer Therapy and Research Center, Department of Psychiatry and Psychotherapy, University Hospital, Ludwig-Maximilians-Universität Munich, Munich, Germany.
Paraskevi SakkaAthens Association of Alzheimer's Disease and Related Disorders, Maroussi, Greece.
Eleni-Zacharoula GeorgiouDepartment of Medicine, School of Health Sciences, Mental Health Services, Patras University General Hospital, University of Patras, 26504, Rio, Patras, Greece.
Μarina CharalampopoulouDepartment of Medicine, School of Health Sciences, Mental Health Services, Patras University General Hospital, University of Patras, 26504, Rio, Patras, Greece.
Panagiotis FelemegkasDepartment of Medicine, School of Health Sciences, Mental Health Services, Patras University General Hospital, University of Patras, 26504, Rio, Patras, Greece.
Iracema LeroiGlobal Brain Health Institute, Medical School, Trinity College Dublin, Dublin, Republic of Ireland.
Apostolos BatsidisDepartment of Mathematics, University of Ioannina, Ioannina, Greece.
Laura PernaDepartment of Genes and Environment, Max Planck Institute of Psychiatry, Munich, Germany.
Antonios Politis1st Department of Psychiatry, Eginition Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Nikolaos Scarmeas1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece.
Polychronis EconomouDepartment of Civil Engineering, School of Engineering, University of Patras, Patras, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Depressive symptoms are common in mild cognitive impairment (MCI), dementia caused by Alzheimer's disease (AD dementia) and in cognitively unimpaired older adults. However, it is unclear whether they could contribute to the identification of cognitive impairment in ageing. To assess the potential utility of depressive symptoms to distinguish between healthy cognitive ageing and MCI and AD dementia. The diagnostic workup of the cognitive function of 1737 older cognitively unimpaired individuals, 334 people with MCI and 142 individuals with AD dementia relied on a comprehensive neuropsychiatric assessment, including the Mini Mental State Examination (MMSE). Depressive symptoms were tapped with the 15-item Geriatric Depression Scale (GDS). Proportional odds logistic regression (POLR) models and the machine learning technique Adaptive Boosting algorithm (AdaBoost) were employed. Stratified repeated random subsampling (stratified bootstrap resampling) was used to recursive partitioning to training- and validation set (70/30 ratio). The average accuracy of the POLR models for the GDS total score in distinguishing between cognitive impairment and healthy cognitive ageing exceeded 78% and was inferior to that of MMSE. Of note, the sensitivity of GDS total score was very low. By employing the AdaBoost algorithm and considering GDS items separately, the average accuracy was higher than 0.72 and comparable to that of the MMSE, while sensitivity- and specificity values were more balanced. The findings of the study provide initial evidence that depressive symptoms may contribute to distinguishing between cognitive impairment and cognitively healthy ageing.

Indexed as

Adaptive boosting algorithmDementia due Alzheimer’s diseaseGeriatric depression scaleMild cognitive impairment

Identifiers

PMID40000465
PMCPMC11861444

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.